9:25

AI x Bio Pitch Contest — Optagon Labs

Khalil Kaddoura presents Optagon Labs' proposed AI-driven loop for drug optimization and lab testing.

Xin

Chapters

  1. 00:00 The drug-optimization bottleneck
  2. 01:37 Models, experiments, and lab feedback
  3. 02:23 Pilot claims and business model
  4. 04:14 Q&A: How the workflow operates
  5. 06:00 Q&A: Customers and model design
  6. 07:52 Q&A: Validation and lab partners
Summary

Optagon Labs CEO Khalil Kaddoura focuses on the experiments needed to optimize a drug candidate before human testing. He outlines a proposed loop of molecular modeling, digital experiments, selected lab tests, and feedback from results. The judges ask how this workflow operates, who uses it, and what the company's validation work includes.

Watch next

More from the studio

TechCrunch Disrupt 2026 · AIEEV3:12Open Mic

TechCrunch Disrupt 2026 · AIEEV

AIEEV co-founder Hyeonkyeong (Karen) Kim explains the approach behind Air Cloud: connecting edge GPU devices for AI inference, supporting container-based deployment and autoscaling, and addressing hardware and network security. Recorded at TechCrunch Disrupt 2026.

Oct 22, 2026
AI x Bio Pitch Contest1:10

AI x Bio Pitch Contest

A short look at the September 29 AI x Bio Pitch Contest in San Francisco, from company pitches to the award presentations.

Oct 5, 2026
AI x Bio Pitch Contest — Umbra Bio7:19

AI x Bio Pitch Contest — Umbra Bio

Paul Donohoue presents Umbra Bio's approach to multi-attribute protein design and answers the judges' questions.

Oct 5, 2026